Literature DB >> 18400974

Differential immune responses of red Deer (Cervus elaphus) following experimental challenge with Mycobacterium avium subsp. paratuberculosis.

Mark Robinson1, Rory O'Brien, Colin Mackintosh, Frank Griffin.   

Abstract

Immune responses of red deer (Cervus elaphus) that presented with different levels of paucibacillary pathology were profiled to detail immune changes during the progression of Johne's disease. Immune responses were monitored using an immunoglobulin G1 (IgG1) antibody enzyme-linked immunosorbent assay (ELISA), a gamma interferon (IFN-gamma) ELISA, and flow cytometry. Animals in the study were divided into outcome groups postmortem according to disease severity. All animals mounted IgG1 antibody and IFN-gamma responses to both the vaccination and experimental challenges. The Mycobacterium avium subsp. paratuberculosis-specific IgG1 antibody responses in the challenged group showed marked differences between infected and severely diseased animals. Slightly higher IFN-gamma responses were seen in infected animals compared with severely diseased animals. No significant changes were seen in the phenotype of lymphocyte populations investigated. Vaccination with killed M. avium subsp. paratuberculosis in mineral oil adjuvant reduced the level of severe disease; however, it obscured immunological differences between the infected and severely diseased groups. This suggests protection is not exclusively mediated via the presence of a type 1 response and, furthermore, the presence of a type 2 response is compatible with protection. These profiles provide information on the different immune processes in Johne's disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400974      PMCID: PMC2446610          DOI: 10.1128/CVI.00031-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  25 in total

Review 1.  Experimental challenge models for Johne's disease: a review and proposed international guidelines.

Authors:  Murray E Hines; Judith R Stabel; Raymond W Sweeney; Frank Griffin; Adel M Talaat; Douwe Bakker; Geart Benedictus; William C Davis; Geoffrey W de Lisle; Ian A Gardner; Ramon A Juste; Vivek Kapur; Ad Koets; Jim McNair; Greg Pruitt; Robert H Whitlock
Journal:  Vet Microbiol       Date:  2007-03-27       Impact factor: 3.293

2.  A study of immunological responses of sheep clinically-affected with paratuberculosis (Johne's disease). The relationship of blood, mesenteric lymph node and intestinal lymphocyte responses to gross and microscopic pathology.

Authors:  C Burrells; C J Clarke; A Colston; J M Kay; J Porter; D Little; J M Sharp
Journal:  Vet Immunol Immunopathol       Date:  1998-12-11       Impact factor: 2.046

3.  Evaluation of the long-term immune response in cattle after vaccination against paratuberculosis in two Dutch dairy herds.

Authors:  J Muskens; F van Zijderveld; A Eger; D Bakker
Journal:  Vet Microbiol       Date:  2002-05-01       Impact factor: 3.293

4.  Vaccination of sheep against M. paratuberculosis: immune parameters and protective efficacy.

Authors:  D J Begg; J F T Griffin
Journal:  Vaccine       Date:  2005-10-10       Impact factor: 3.641

5.  Evaluation of five antibody detection tests for diagnosis of bovine paratuberculosis.

Authors:  Michael T Collins; Scott J Wells; Kristine R Petrini; James E Collins; Ronald D Schultz; Robert H Whitlock
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

6.  Subclinical paratuberculosis in goats following experimental infection. An immunological and microbiological study.

Authors:  A K Storset; H J Hasvold; M Valheim; H Brun-Hansen; G Berntsen; S K Whist; B Djønne; C M Press; G Holstad; H J Larsen
Journal:  Vet Immunol Immunopathol       Date:  2001-08-10       Impact factor: 2.046

7.  Experimental infections in young red deer (Cervus elaphus) with a bovine and an ovine strain of Mycobacterium avium subsp paratuberculosis.

Authors:  C G Mackintosh; R E Labes; R G Clark; G W de Lisle; J F T Griffin
Journal:  N Z Vet J       Date:  2007-02       Impact factor: 1.628

8.  Analysis of the immune response to Mycobacterium avium subsp. paratuberculosis in experimentally infected calves.

Authors:  Hye Cheong Koo; Yong Ho Park; Mary Jo Hamilton; George M Barrington; Christopher J Davies; Jong Bae Kim; John L Dahl; W Ray Waters; William C Davis
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

9.  Progressive bovine paratuberculosis is associated with local loss of CD4(+) T cells, increased frequency of gamma delta T cells, and related changes in T-cell function.

Authors:  Ad Koets; Victor Rutten; Aad Hoek; Frans van Mil; Kerstin Müller; Douwe Bakker; Erik Gruys; Willem van Eden
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection model.

Authors:  Jude E Uzonna; Paula Chilton; Robert H Whitlock; Perry L Habecker; Phillip Scott; Raymond W Sweeney
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

View more
  4 in total

Review 1.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

2.  Longitudinal Pathogenesis Study of Young Red Deer (Cervus elaphus) after Experimental Challenge with Mycobacterium avium subsp. paratuberculosis (MAP).

Authors:  Colin Mackintosh; Gary Clark; Brendan Tolentino; Simon Liggett; Geoff de Lisle; Frank Griffin
Journal:  Vet Med Int       Date:  2012-06-06

3.  Competition for antigen between Th1 and Th2 responses determines the timing of the immune response switch during Mycobaterium avium subspecies paratuberulosis infection in ruminants.

Authors:  Gesham Magombedze; Shigetoshi Eda; Vitaly V Ganusov
Journal:  PLoS Comput Biol       Date:  2014-01-09       Impact factor: 4.475

4.  Innate immune markers that distinguish red deer (Cervus elaphus) selected for resistant or susceptible genotypes for Johne's disease.

Authors:  Brooke Dobson; Simon Liggett; Rory O'Brien; J Frank T Griffin
Journal:  Vet Res       Date:  2013-01-24       Impact factor: 3.683

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.